ANI Pharmaceuticals完成对Alimera Sciences的收购
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)已经完成了对Alimera Sciences, Inc.的收购,这一举措显著扩大了其眼科产品组合。该交易于周一完成,ANI Pharmaceuticals作为母公司,将Alimera吸收为全资子公司。 根据协议条款,Alimera的股东将获得每股5.50美元的现金,外加一个或有价值权(CVR)。如果ILUVIEN®和YU ...
ANI Pharmaceuticals completes purchase of Alimera Sciences
ANI Pharmaceuticals (ANIP)  said it completed its planned acquisition of Alimera Sciences (NASDAQ:ALIM). Under the terms of ...
ophthalmologytimes4 天
ANI Pharmaceuticals completes acquisition of Alimera Sciences
The acquisition strengthens the company’s rare disease segment, and adds 2 durable commercial assets, Iluvien and Yutiq with ...
Alimera Sciences falls after it sues ANI Pharmaceuticals to close deal (update)
Alimera Sciences (NASDAQ:ALIM) plummeted 25% in premarket trading after it said it filed a lawsuit against ANI ...
ANI Pharmaceuticals和Alimera Sciences将于9月16日完成合并
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP)和Alimera Sciences, Inc. (NASDAQ: ALIM)宣布,计划于2024年9月16日(星期一)开市前完成合并协议。这符合之前披露的交易条款。 ANI Pharmaceuticals以其多元化的生物制药产品组合而闻名,专注于品牌和仿制处方药。该公司一直致力于扩大其罕见病业务,增强仿制药业务,并利用 ...
ANI Pharmaceuticals’ Acquisition of Alimera Sciences Bolsters Buy Rating and $94 Target Price
In a report released today, Oren Livnat from H.C. Wainwright reiterated a Buy rating on ANI Pharmaceuticals (ANIP – Research Report), ...
ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences
Strengthens Rare Disease segment as largest driver of future growth, adding approximately $105 million in 2024 revenue on a pro forma basisAdds ...
ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences
PRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ANIP) (“ANI” or the “Company”) announced today that the Company ...
Alimera Sciences: Deal Closing After All, CVR Still Attractive
ANI Pharmaceuticals acquiring Alimera Sciences for $5.50 per share with potential for $0.50 per share CVR, offering an ...
ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences
PRINCETON, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- (“ANI” or “the Company”) (Nasdaq: ANIP) today provided an update on the ...
Drug Store News10 天
Alimera Sciences takes legal action against ANI Pharmaceuticals to enforce merger agreement
Alimera’s lawsuit asks the court to require ANI to comply with its obligations to complete the transaction as contemplated by ...
ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera ...
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) ("ANI" or the "Company") announced today that the Company has initiated closing logistics for the previously ...